Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update

Go back to Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update
(NASDAQ: BNTC) Delayed: 13.63 +0.75 (5.82%)
Previous Close $12.88    52 Week High $5.64 
Open $12.97    52 Week Low $1.20 
Day High $13.81    P/E N/A 
Day Low $12.62    EPS $0.00 
Volume 192,412